Effect of parenteral magnesium sulfate administration on excitatory amino acid receptors in the rat brain

Magnesium Research

Volumn 11, Issue 2, 1998, Pages 117-131

  Hallak, Mordechai ^a,b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c NONE

Author keywords

Brain; Magnesium sulfate; NMDA receptor; Non NMDA receptor; Rat

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; AMPA RECEPTOR; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; KAINIC ACID RECEPTOR; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL; BLOOD BRAIN BARRIER; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; INFUSION; METABOLISM; RAT; REVIEW; SEIZURE;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; HIPPOCAMPUS; INFUSIONS, PARENTERAL; MAGNESIUM SULFATE; RATS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES;

EID: 0032087639     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. American College of Obstetricians and Gynecologists (1986): Management of preeclampsia. Technical Bulletin No. 91.
2. Pritchard, J.A., Cunningham, F.G. & Pritchard, S.A. (1984): The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am. J. Obstet. Gynecol. 148, 951-963.
3. Pritchard, J.A. (1979): The use of magnesium sulfate in preeclampsia-eclampsia. J. Reprod. Med. 23, 107-114.
4. Redman, C.W.G. & Roberts, J.M. (1993): Management of pre-eclampsia. Lancet 341, 1451-1454.
5. The Eclampsia Trial Collaborative Group (1995): Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 345, 1455-1463.
6. Lucas, M.J., Leveno, K.J. & Cunningham, F.G. (1995): A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med. 333, 201-205.
7. Roberts, J.M. (1995): Magnesium for preeclampsia and eclampsia. N. Engl. J. Med. 333, 250-251.
8. Kato, G. & Smojen, G.G. (1969): Effects of microiontophoretic administration of magnesium and calcium on neurons in the central nervous system of cats. J. Neurobiol. 2, 181-185.
9. Borges, L.F. & Gucer, G. (1978): Effect of magnesium on epileptic foci. Epilepsia 19, 81-91.
10. Chutkow, J.G. (1974): Metabolism of magnesium in central nervous system. Relationship between concentrations of magnesium in cerebrospinal fluid and brain in magnesium deficiency. Neurology 24, 180-187.
11. Fisher, R.S., Kaplan, P.W., Krumholz, A., Lesser, R.P., Rosen, S.A. & Wolff, M.R. (1988): Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin. Neuropharmacol. 11, 537-544.
12. Donaldson, J.O. (1988): Eclamptic hypertensive encephalopathy Semin. Neurol. 8, 230-233.
13. Donaldson, J O. (1986): Does magnesium sulfate treat eclamptic convulsions? Clin. Neuropharmacol. 9, 37-45.
14. Kaplan, P.W., Lesser, R.P., Fisher, R.S., Repke, J.T. & Hanley, D.F. (1988): No, magnesium sulfate should not be used in treating eclamptic seizures. Arch. Neurol. 45, 1361-1364.
15. Hilmy, M.I. & Smojen, G.G. (1968): Distribution and tissue uptake of magnesium related to its pharmacological effects. Am. J. Physiol. 214, 406-413.
16. Pritchard, J.A. (1955): The use of the magnesium ion in the management of eclamptic toxemias. Surg. Gynecol. Obstet. 100, 131-140.
17. Ramanathan, J., Sibai, B.M., Pillai, R. & Angle, J.J. (1988): Neuromuscular transmission studies in preeclamptic women receiving magnesium sulfate. Am. J. Obstet. Gynecol. 158, 40-46.
18. Smojen, G., Hilmy, M. & Stephen, C.R. (1966): Failure to anesthetize human subjects by intravenous administration of magnesium sulfate. J. Pharmacol. Exp. Ther. 154, 652-659.
19. Hibbard, B.M. & Rosen, M. (1977): The management of severe pre-eclampsia and eclampsia. Br. J. Anaesth. 49, 3-9.
20. Watkins, J.C. & Evans, R.H. (1981): Excitatory ammo acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21, 165-204.
21. Monaghan, D.T., Bridges, R.J. & Cotman, C.W. (1989): The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29, 365-402.
22. Farooqui, A.A. & Horrocks, L.A. (1991): Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders Brain Res. Rev. 16, 171-191.
23. Kleckner, N.W. & Dingledine, R. (1991): Regulation of hippocampal NMDA receptors by magnesium and glycine during development. Mol. Brain Res. 11, 151-159.
24. McDonald, J.W., Silverstein, F.S. & Johnston, M.V. (1988): Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 459, 200-203.
25. McDonald, J.W., Silverstein, F.S. & Johnston, M.V. (1990): Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neuroscl. Lett. 109, 234-238.
26. Schoepp, D.D., Gamble, A.Y., Salhoff, C.R., Johnson, B.G. & Ornstein, P.L. (1990): Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. Eur. J. Pharmacol 182, 421-427.
27. Peeters, B.W.M.M., Rijn van, C.M., Vossen, J.M.H. & Coenen, A.M.L. (1990): Involvement of NMDA receptors in non-convulsive epilepsy in Wag/Rij rats. Life Sci. 47, 523-529.
28. Suyama, K. (1992): Changes of neuronal transmission in the hippocampus after transient ischemia in spontaneously hypertensive rats and the protective effects of MK-801. Stroke 23, 260-266.
29. Lipton, S.A. & Rosenberg, P.A. (1994): Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.
30. Young, A.B. & Fagg, G.E. (1990): Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11, 126-1233.
31. Dingledine, R., McBain, J.C. & McNamara, O.J. (1990): Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11, 334-338.
32. Kulkarni, S.K., Mehta, A.K. & Ticku, M.K. (1990): Comparison of anticonvulsant effect of ethanol against NMDA-kainic acid- and picrotoxin-induced convulsions in rats. Life Sci. 46, 481-487.
33. Sato, K., Morimoto, K. & Okamoto, M. (1988): Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Brain Res. 463, 12-20.
34. McNamara, J.O., Russell, R.D., Rigsbee, L. & Bonhaus, D.W. (1988): Anticonvulsant and antiepileptogenic actions of MK-810 in the kindling and electroshock models. Neuropharmacology 27, 563-568.
35. Moreau, J.L., Pieri, L. & Prud'hon, B. (1989): Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants. Br. J. Pharmacol. 98, 1050-1054.
36. Morimoto, K., Katayama, K., Inoue, K. & Sato, K. (1991): Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol. Biochem. Behav. 40, 893-899.
37. Gilbert, M.E. (1988): The NMDA-receptor antagonist, MK-801. suppresses limbic kindling and kindled seizures. Brain Res. 463, 90-99.
38. Olney, J.W. (1989): Excitotoxicity and N-methyl-D-aspartate receptors. Drug Dev. Res. 17, 299-319.
39. Sombati, S., Coulter, D.A. & DeLorenzo, R.J. (1991): Neurotoxic activation of glutamate receptors induces an extended neuronal depolarization in cultured hippocampal neurons. Brain Res. 566, 316-319.
40. Ascher, P. & Nowak, L. (1988): The role of divalent cations in the N-methyl-D-aspartatc responses of mouse central neurons in culture. J. Physiol. (London) 399, 247-266.
41. Mayer, M.L. & Westbrook, G.L. (1987): Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurons. J. Physiol. (London) 394, 501-527.
42. 2+ of NMDA responses in spinal cord neurons. Nature 309, 261-263.
43. McMaster, O.G., Du, F., French, E.D. & Schwarcz, R. (1991): Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: Evidence for mediation by NMDA receptors. Exp. Neurol. 113, 378-385.
44. Wolf, G., Keilhoff, G., Fisher, S. & Hass, P. (1990): Subcutaneously applied magnesium protects reliably against qumohnate-induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: are there therapeutical implications? Neurosci. Lett. 117, 207-211.
45. Katz, A., Kerem, D. & Sherman, D. (1990): Magnesium sulfate suppresses electroencephalographic manifestations of CNS oxygen toxicity. Undersea Biomed. Res. 17, 45-49.
46. 2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neuroscience 44, 335-341.
47. Katz, B. & Miledi. R. (1969): Tetrodotoxin-resistant electric activity in presynaptic terminals. J. Physiol. (Lond) 203, 459-487.
48. Hallak, M., Berman, R.F., Irtenkauf, S.M., Evans, M.I. & Cotton, D.B. (1992): Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am. J. Obstet. Gynecol. 167, 1605-1610.
49. Hallak, M., Irtenkauf, S.M., Janusz, C.A. & Cotton, D.B. (1993): Stimulation and inhibition of N-methyl-D-aspartate receptors in rats: Developing a seizure model Am. J. Obstet. Gynecol. 169, 695-700.
50. Paxinos, G. & Watson, C. (1986): The rat brain in stereotaxic coordinates. New York: Academic Press.
51. Cotton, D.B., Janusz, C.A. & Berman, R.F. (1992): Anticonvulsant effects of magnesium sulfate on hippocampal seizure: Therapeutic implications in preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 166, 1127-1136.
52. Cotton, D.B., Hallak, M., Janusz, C., Irtenkauf, S.M. & Berman, R.F. (1993): Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Am, J. Obstet. Gynecol. 168, 974-978.
53. Hallak, M., Berman, R.F., Irtenkauf, S.M., Janusz, A.C. & Cotton, D.B. (1994): Magnesium sulfate treatment decreases N-Methyl-D-Aspartate receptor binding in the rat brain: An autoradiographic study. J. Soc. Gynecol. Invest. 1, 25-30.
54. Hallak, M., Irtenkauf, S.M. & Cotton, D.B. (1996): Effect of magnesium sulfate on excitatory amino acid receptors in the rat brain: I. N-Methyl-D-aspartate receptor-channel complex. Am. J. Obstet. Gynecol. 175, 575-581.
55. Hallak, M., Irtenkauf, S.M. & Cotton, D.B. (1996): Effect of magnesium sulfate on excitatory amino acid receptors in the rat brain: II. Kainate and a-amino-3-hydroxy-5-methylisoxasole-4-propionic acid receptors. Am. J. Obstet. Gynecol. 175, 582-587.